These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 13919041)

  • 1. [On the metabolism of PAS. III. With special reference to the relation between the PAS-Ca concentration in the blood and PAS glycosuria].
    TAKAHASHI H
    Yokohama Med Bull; 1961 Aug; 12():146-50. PubMed ID: 13919041
    [No Abstract]   [Full Text] [Related]  

  • 2. [On the metabolism of PAS. II. With special reference to PAS-Ca-glycosuria].
    TAKAHASHI H
    Yokohama Med Bull; 1961 Aug; 12():141-5. PubMed ID: 13919040
    [No Abstract]   [Full Text] [Related]  

  • 3. [On the metabolism of PAS. IV. With special reference to the different forms of glucuronic acid in PAS-glycosuria].
    TAKAHASHI H
    Yokohama Med Bull; 1961 Aug; 12():151-9. PubMed ID: 13919042
    [No Abstract]   [Full Text] [Related]  

  • 4. [On the metabolism of PAS. V. With special reference to the relation between the blood and urine sugar levels and PAS-glycosuria during insulin administration].
    TAKAHASHI H
    Yokohama Med Bull; 1961 Aug; 12():160-2. PubMed ID: 13919043
    [No Abstract]   [Full Text] [Related]  

  • 5. [The metabolism of PAS with special reference to PAS-glycosuria. I].
    TAKAHASHI H
    Yokohama Med Bull; 1959 Jun; 10():155-66. PubMed ID: 13836638
    [No Abstract]   [Full Text] [Related]  

  • 6. [PAS glycosuria and hyperglycemia].
    ROBEL G
    Tuberkulosearzt; 1953 Apr; 7(4):224-5. PubMed ID: 13090326
    [No Abstract]   [Full Text] [Related]  

  • 7. The use of benemid to enhance blood-levels of sodium para-aminosalicylate (PAS).
    MCLEOD JA; TURNBULL FW; CROFTON JW
    Tubercle; 1953 Jun; 34(6):152-5. PubMed ID: 13077745
    [No Abstract]   [Full Text] [Related]  

  • 8. [PAS concentration in the pulmonary tuberculosis lesion. Part III. The residual condition of PAS-Na after its oral administration].
    HASHIMOTO T
    Kekkaku; 1960 Feb; 35():131-4. PubMed ID: 13851960
    [No Abstract]   [Full Text] [Related]  

  • 9. [Contribution to the current status of chemotherapy of pulmonary tuberculosis].
    PAUL K
    Acta Tuberc Scand; 1960; 38():82-90. PubMed ID: 14430995
    [No Abstract]   [Full Text] [Related]  

  • 10. PARA-AMINOSALICYLIC acid (PAS) and streptomycin in pulmonary tuberculosis; comparison between 84 PAS-treated and 82 streptomycin-treated cases.
    Acta Tuberc Scand; 1952; 27(3-5):157-75. PubMed ID: 13040105
    [No Abstract]   [Full Text] [Related]  

  • 11. [PAS concentration in the blood in pulmonary tuberculosis treated by PAS; comparison with radioclinical results].
    VERAN P; LASAUSSE
    Paris Med; 1950 Oct; 40(39):546-7. PubMed ID: 14797292
    [No Abstract]   [Full Text] [Related]  

  • 12. [PAS concentration in the pulmonary tuberculosis lesion. Part I. Punctual movement of PAS-Na concentration intravenously injected. I].
    HASHIMOTO T
    Kekkaku; 1959 Dec; 34():870-5. PubMed ID: 13851958
    [No Abstract]   [Full Text] [Related]  

  • 13. Para-aminosalicylic acid (PAS) in cavernous pulmonary tuberculosis; oral treatment; comparison between the effects of PAS in oral and transthoracic administration.
    DIFS H
    Acta Tuberc Scand; 1951; 25(2-3):128-63. PubMed ID: 14810565
    [No Abstract]   [Full Text] [Related]  

  • 14. Can we rely upon the fact that the different PAS-preparations really will be resorbed in the gastrointestinal tract after oral dosage? Some observations during PAS treatment in pulmonary tuberculosis.
    FROSTAD S
    Acta Tuberc Scand; 1960; 39():303-7. PubMed ID: 13702286
    [No Abstract]   [Full Text] [Related]  

  • 15. [PAS concentration in the pulmonary tuberculosis lesion. Part II. Periodical change of PAS-Na concentration intravenously injected. II].
    HASHIMOTO T
    Kekkaku; 1960 Jan; 35():24-8. PubMed ID: 13851959
    [No Abstract]   [Full Text] [Related]  

  • 16. [Perfusions with solutions of para-aminosalicylic acid (PAS) in the treatment of pulmonary tuberculosis].
    PARAF J; ZIVY P; DESBORDES J; BORY I; PARAF
    Bull Acad Natl Med; 1951 Nov-Dec 4; 135(35-36):622-4. PubMed ID: 14925494
    [No Abstract]   [Full Text] [Related]  

  • 17. [Treatment in pulmonary tuberculosis with subcutaneous (Para-Aminosalicylic Acid) PAS infusisons].
    Berger G; Kirschner H
    Tuberkulosearzt; 1956 Mar; 10(3):154-60. PubMed ID: 13324973
    [No Abstract]   [Full Text] [Related]  

  • 18. [Blood concentration in the treatment of pulmonary tuberculosis with intravenous PAS].
    HAIZMANN R; HECHT A
    Beitr Klin Tuberk Spezif Tuberkuloseforsch; 1956; 115(5):365-75. PubMed ID: 13341835
    [No Abstract]   [Full Text] [Related]  

  • 19. [PAS therapy of pulmonary tuberculosis; further findings on clinical hemorrhagic manifestations and on the hematological findings in tuberculotics in general and in those treated with PAS].
    MIGLIORE M; MECHETTI G
    Prog Med (Napoli); 1951 Apr; 7(8):238-40. PubMed ID: 14844502
    [No Abstract]   [Full Text] [Related]  

  • 20. [Studies on variation of the mode of reactivity of the organism in tuberculosis in relation to streptomycin and PAS therapy].
    ERBER B
    G Ital Della Tuberc; 1952; 6(2):100-9. PubMed ID: 14955137
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.